Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study

BACKGROUND: The preferred immunosuppressive drug for long term treatment of myasthenia gravis (MG) is azathioprine (AZA). Mycophenolate mofetil (MMF) was suggested as an effective and safe second line alternative to AZA. METHODS: In a prospective open-label study, 11 patients with acetylcholine rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanisch, F, Wendt, M, Zierz, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352168/
https://www.ncbi.nlm.nih.gov/pubmed/19666397
http://dx.doi.org/10.1186/2047-783X-14-8-364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352168/
https://www.ncbi.nlm.nih.gov/pubmed/19666397
http://dx.doi.org/10.1186/2047-783X-14-8-364

Ejemplares similares